Tuberculosis Stories
Researchers in South Africa believe that they may have found a new avenue toward fighting the deadly disease.
A new study has found that a recently developed breath test may cut down the time of a tuberculosis test from weeks to minutes.
The majority of people infected with the tuberculosis live with no symptoms and die of other causes. Researchers have discovered why, and hope that their finding will lead to a new vaccine.- FDA approved Sirturo (bedaquiline) to treat multiple drug resistant tuberculosis in adults when all other treatments fail.
Ten years ago, WHO developed a policy that targeted the strains of tuberculosis that were easiest to cure. That policy, however, gave rise to the deadliest and most drug-resistant strains.- The number of people in the world newly infected with tuberculosis fell again last year, dropping by 2.2 percent.
Cuts in global funding for Eastern Europe and Central Asia are undermining the fight against tuberculosis (TB) and the AIDS virus, threatening to push already high rates of disease and drug-resistance even higher.
A drug that costs just two cents for a daily dose can treat tuberculosis, even a drug-resistant form of the disease, new research says.
According to Dr. Adrian Martineau, of the Queen Mary University of London, vitamin D can be a useful extra weapon in combating tuberculosis.- Scientists have found an alarming number of cases of the lung disease tuberculosis in Africa, Asia, Europe and Latin America that are resistant to up to four powerful antibiotic drugs.
Homeless people across the world have dramatically higher rates of infection with tuberculosis (TB), HIV and hepatitis C and could fuel community epidemics that cost governments dear.
The pill is implanted with a microchip that is about the size of a grain of sand that reacts with digestive materials.